Your session is about to expire
← Back to Search
PPA Tele-Savvy Pilot Intervention for Primary Progressive Aphasia
N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6-week follow-up
Awards & highlights
Study Summary
This trial is testing an online education program to help caregivers of people with PPA. The goal is to help caregivers feel more confident and skilled in caring for their loved ones.
Who is the study for?
This trial is for informal caregivers aged 18 or over who help someone with Primary Progressive Aphasia (PPA) for at least two hours daily. Participants must be comfortable using computers and videoconferencing, have good internet access, and can read and understand English without significant vision or hearing issues.Check my eligibility
What is being tested?
The study tests an online program called PPA Tele-Savvy designed to educate caregivers of people with PPA. It aims to provide them with skills to manage caregiving challenges effectively and improve their well-being.See study design
What are the potential side effects?
Since this intervention is educational and supportive in nature rather than medical, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6-week follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Caregiver Mastery Pearlin Caregiver Stress Scale Score
Secondary outcome measures
Change in Behavioral and Psychological Symptoms of Dementia Revised Memory and Behavior Problem Checklist (RMBPC) score
Change in Care recipient quality of life DEMQOL: Dementia Quality of Life Measure (Carer v4) score
Change in Caregiver Burden The Zarit Burden Interview score
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PPA Tele-Savvy Pilot InterventionExperimental Treatment1 Intervention
The Tele-Savvy program is comprised of weekly, two-hour interactive classes, over seven consecutive weeks, the same duration as the proposed intervention. Tele-Savvy consists of educational instruction, video and in-class exercises that engage participants on a functional level. Course material was designed to provide informal caregivers with the knowledge, skills, and attitude needed to carry out their role as a caregiver for a person living with dementia (PLWD). Course learning objectives include: 1) introduction to dementing disorder; 2) caregiver self-care; 3) the anchors of contented involvement; 4) levels of thinking and performance; 5) strengthening the family as a resource for caregiving; and 6) review and integration of the previous sections.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,163 Total Patients Enrolled
Emory UniversityOTHER
1,638 Previous Clinical Trials
2,560,464 Total Patients Enrolled
Darby Morhardt, PhDStudy Chair - Northwestern University
Northwestern University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: PPA Tele-Savvy Pilot Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger